Tylenol maker Kenvue rebounds after Trump spreads unproven claims
At the opening of trading, Kenvue shares bounced back by more than 6%.
Shares of Tylenol maker Kenvue bounced back sharply at the opening bell Tuesday, a day after President Donald Trump promoted unproven and, in some cases, discredited ties between Tylenol, vaccines, and autism.
No comments have been added yet.
David Lidsky's Blog
- David Lidsky's profile
- 3 followers
David Lidsky isn't a Goodreads Author
(yet),
but they
do have a blog,
so here are some recent posts imported from
their feed.
